RxNorm Semantic Concepts Index - 218
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "218".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 2180 | ceFAZolin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2180 | ceFAZolin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2180 | ceFAZolin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2180 | ceFAZolin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2180 | ceFAZolin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2180 | ceFAZolin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 218000 | Levotabs | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218001 | Levothroid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218002 | Levoxyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218003 | Levsin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218004 | Levsin with Phenobarbital | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218004 | Levsin with Phenobarbital | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 218006 | Lexxel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218007 | Libritabs | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218009 | Lice Treatment Maximum Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218011 | Lice-Aid Shampoo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218012 | Lice-X Liquid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218013 | Licon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218019 | Lidomar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218021 | Lincorex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2180253 | Abrus precatorius whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2180254 | Anacardium occidentale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2180255 | tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2180256 | Sinapis alba whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2180257 | Agaricus bisporus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2180258 | Etlingera elatior whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 218026 | Liposyn III | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218027 | Lipram | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218028 | Liqui Doss | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218030 | Liqui-Char | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218031 | Liqui-Char with Sorbitol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218032 | Liqui-Flur | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2180325 | darolutamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2180325 | darolutamide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2180325 | darolutamide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2180325 | darolutamide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2180325 | darolutamide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2180326 | darolutamide 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2180327 | darolutamide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2180327 | darolutamide Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2180327 | darolutamide Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2180328 | darolutamide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2180329 | darolutamide Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 218033 | Liqui-Histine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2180330 | darolutamide 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180330 | darolutamide 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2180331 | Nubeqa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2180332 | darolutamide 300 MG [Nubeqa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2180333 | darolutamide Oral Tablet [Nubeqa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180334 | Nubeqa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2180335 | Nubeqa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2180336 | NUBEQA 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180336 | NUBEQA 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180336 | NUBEQA 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2180337 | influenza A virus A/Idaho/07/2018 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2180338 | influenza A virus A/Indiana/08/2018 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 218034 | Liqui-Histine-D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2180341 | Tovet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2180342 | clobetasol propionate 0.5 MG/ML [Tovet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2180343 | clobetasol Topical Foam [Tovet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180344 | Tovet Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2180345 | Tovet 0.05 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180345 | Tovet 0.05 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180345 | Tovet 0.05 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2180346 | Enzoclear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2180347 | benzoyl peroxide 98 MG/ML [Enzoclear] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2180348 | benzoyl peroxide Topical Foam [Enzoclear] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180349 | Enzoclear Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 218035 | Liqui-Minic Infant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2180350 | Enzoclear 9.8 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180350 | Enzoclear 9.8 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180350 | Enzoclear 9.8 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 218036 | Liquibid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2180398 | influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2180399 | influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2180400 | influenza A virus A/Idaho/07/2018 (H1N1) antigen / influenza A virus A/Indiana/08/2018 (H3N2) antigen / influenza B virus B/Iowa/06/2017 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2180401 | influenza virus vaccine 2019-2020 (quadrivalent - Idaho/Indiana/Iowa/Singapore) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2180401 | influenza virus vaccine 2019-2020 (quadrivalent - Idaho/Indiana/Iowa/Singapore) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180401 | influenza virus vaccine 2019-2020 (quadrivalent - Idaho/Indiana/Iowa/Singapore) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2180402 | Flucelvax Quadrivalent 2019-2020 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2180403 | influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2019-2020] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2180404 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2019-2020] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180405 | Flucelvax Quadrivalent 2019-2020 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2180406 | FLUCELVAX Quadrivalent 2019-2020 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180406 | FLUCELVAX Quadrivalent 2019-2020 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180406 | FLUCELVAX Quadrivalent 2019-2020 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2180407 | influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2180408 | influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2019-2020] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2180409 | influenza virus vaccine 2019-2020 (quadrivalent - Idaho/Indiana/Iowa/Singapore) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2180409 | influenza virus vaccine 2019-2020 (quadrivalent - Idaho/Indiana/Iowa/Singapore) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180409 | influenza virus vaccine 2019-2020 (quadrivalent - Idaho/Indiana/Iowa/Singapore) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2180410 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2019-2020] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180411 | FLUCELVAX Quadrivalent 2019-2020 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180411 | FLUCELVAX Quadrivalent 2019-2020 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2180411 | FLUCELVAX Quadrivalent 2019-2020 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180412 | Astacus crayfish whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2180413 | magnesium citrate 16000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2180414 | magnesium citrate Powder for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2180415 | magnesium citrate 16 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2180415 | magnesium citrate 16 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2180415 | magnesium citrate 16 GM Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2180416 | magnesium citrate 16000 MG [Ez2go Stimu-Lax Powder] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2180417 | magnesium citrate Powder for Oral Solution [Ez2go Stimu-Lax Powder] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2180418 | Ez2go Stimu-Lax Powder Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2180419 | Ez2go Stimu-Lax Powder 16 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2180419 | Ez2go Stimu-Lax Powder 16 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2180419 | Ez2go Stimu-Lax Powder 16 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2180419 | Ez2go Stimu-Lax Powder 16 GM Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2180420 | magnesium citrate 17 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2180420 | magnesium citrate 17 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2180420 | magnesium citrate 17 GM Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 218045 | Liquiprin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218050 | Little Bottoms Diaper Rash | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218051 | Little Noses | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218052 | Little Tummys | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2180545 | Swertia chirayita whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2180546 | Acacia dealbata flower wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2180547 | Agave polianthes flower wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2180548 | Helichrysum litoreum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2180549 | Lavandula angustifolia flower wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 218055 | Lo-Aqua | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2180550 | Narcissus poeticus flower wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2180551 | Rosa centifolia flower wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2180552 | damask rose flower wax | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2180552 | damask rose flower wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2180553 | Gloperba | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2180554 | colchicine 0.12 MG/ML [Gloperba] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2180555 | colchicine Oral Solution [Gloperba] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180556 | Gloperba Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2180557 | Gloperba Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2180558 | Gloperba 0.6 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180558 | Gloperba 0.6 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2180558 | Gloperba 0.6 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180558 | Gloperba 0.6 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2180647 | loratadine 5 MG [Wal-itin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2180648 | loratadine Chewable Tablet [Wal-itin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180649 | Wal-itin Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2180650 | Wal-itin 5 MG 24HR Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180650 | Wal-itin 5 MG 24HR Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2180650 | Wal-itin 5 MG 24HR Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180654 | tetracycline hydrochloride 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2180655 | tetracycline Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2180656 | tetracycline HCl 3 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2180656 | tetracycline HCl 3 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2180657 | Vitastem | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2180658 | tetracycline hydrochloride 30 MG/ML [Vitastem] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2180659 | tetracycline Topical Spray [Vitastem] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2180660 | Vitastem Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2180661 | VITASTEM 3 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2180661 | VITASTEM 3 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2180661 | VITASTEM 3 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2180661 | VITASTEM 3 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2180663 | glucagon 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2180664 | Glucagon-containing product in nasal dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2180664 | Glucagon-containing product in nasal dose form | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2180664 | Glucagon-containing product in nasal dose form | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2180665 | glucagon Nasal Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2180666 | glucagon 3 MG Nasal Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180666 | glucagon 3 MG Nasal Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2180667 | Baqsimi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2180668 | glucagon 3 MG [Baqsimi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2180669 | glucagon Nasal Powder [Baqsimi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180670 | Baqsimi Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2180671 | baqsimi 3 MG Nasal Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180671 | baqsimi 3 MG Nasal Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2180671 | baqsimi 3 MG Nasal Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 218068 | Lomocot | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218069 | Long Acting Nasal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218071 | Lonox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218072 | Lopressor HCT | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218073 | Loqua | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218074 | Lorabid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218079 | Loroxide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2180790 | solketal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 218083 | Lortab ASA | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218085 | Losospan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218086 | Losospan Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218087 | Lotemax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218088 | Lotensin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218089 | Lotensin HCT | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218090 | Lotrel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218093 | Lotrisone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218094 | Lotussin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218097 | Low Sodium Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218099 | Lowsium | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2180996 | deferiprone 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2180997 | deferiprone 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180997 | deferiprone 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2180998 | deferiprone 1000 MG [Ferriprox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2180999 | Ferriprox 1000 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2180999 | Ferriprox 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2180999 | Ferriprox 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 218100 | Lowsium Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218101 | Loxitane C | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218102 | Lozol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218109 | Lufyllin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218111 | Lufyllin-EPG | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218112 | Lufyllin-GG | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218115 | Luride | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218117 | Lurline PMS | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218118 | Lustra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218119 | Lutrepulse | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218124 | M-Caps | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218125 | M-Clear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218126 | M-End | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218128 | M-M-R II | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218129 | M-Oxy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2181292 | pheniramine maleate 16 MG / phenylpropanolamine hydrochloride 50 MG / phenyltoloxamine citrate 16 MG / pyrilamine maleate 16 MG [Poly Histine D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 218130 | M-Phen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2181301 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 1.25 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181301 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 1.25 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2181301 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 1.25 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2181302 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 1.25 MG / phenylephrine hydrochloride 20 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181303 | dexchlorpheniramine maleate 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2181304 | dexchlorpheniramine maleate 6 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2181304 | dexchlorpheniramine maleate 6 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2181304 | dexchlorpheniramine maleate 6 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2181304 | dexchlorpheniramine maleate 6 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2181305 | dexchlorpheniramine maleate 6 MG / phenylephrine hydrochloride 40 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181306 | Meticillin-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2181306 | Meticillin-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2181306 | Meticillin-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2181306 | Meticillin-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2181306 | Meticillin-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2181306 | Meticillin-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2181306 | Meticillin-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2181307 | acetaminophen 325 MG / caffeine 45 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2181307 | acetaminophen 325 MG / caffeine 45 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2181307 | acetaminophen 325 MG / caffeine 45 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2181307 | acetaminophen 325 MG / caffeine 45 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2181308 | chlorpheniramine maleate 0.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2181309 | chlorpheniramine maleate 0.25 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181310 | chlorpheniramine tannate 4.5 MG / phenylephrine tannate 5 MG per 5 ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181310 | chlorpheniramine tannate 4.5 MG / phenylephrine tannate 5 MG per 5 ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2181311 | chlorpheniramine tannate 1.6 MG/ML / phenylephrine tannate 3 MG/ML / pyrilamine tannate 2.5 MG/ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181312 | chlorpheniramine maleate 12 MG / phenylpropanolamine HCl 75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2181312 | chlorpheniramine maleate 12 MG / phenylpropanolamine HCl 75 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181313 | chlorpheniramine maleate 12 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2181313 | chlorpheniramine maleate 12 MG Oral Capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2181313 | chlorpheniramine maleate 12 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2181313 | chlorpheniramine maleate 12 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181313 | chlorpheniramine maleate 12 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2181314 | pyrilamine maleate 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2181315 | chlorpheniramine maleate 2 MG / phenylephrine HCl 10 MG / pyrilamine maleate 10 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2181315 | chlorpheniramine maleate 2 MG / phenylephrine HCl 10 MG / pyrilamine maleate 10 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181316 | chlorpheniramine maleate 2 MG / phenylephrine HCl 10 MG / pyrilamine maleate 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2181316 | chlorpheniramine maleate 2 MG / phenylephrine HCl 10 MG / pyrilamine maleate 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181317 | chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG / phenylpropanolamine HCl 50 MG / pyrilamine maleate 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2181317 | chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG / phenylpropanolamine HCl 50 MG / pyrilamine maleate 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2181317 | chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG / phenylpropanolamine HCl 50 MG / pyrilamine maleate 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181317 | chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG / phenylpropanolamine HCl 50 MG / pyrilamine maleate 25 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2181317 | chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG / phenylpropanolamine HCl 50 MG / pyrilamine maleate 25 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2181318 | chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG / pyrilamine maleate 25 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2181318 | chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG / pyrilamine maleate 25 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181319 | chlorpheniramine maleate 8 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2181319 | chlorpheniramine maleate 8 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2181319 | chlorpheniramine maleate 8 MG Oral Capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2181319 | chlorpheniramine maleate 8 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2181319 | chlorpheniramine maleate 8 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218134 | M.A.H. | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218136 | M.T.E.-5 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218138 | M.T.E.-6 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218139 | M.T.E.-7 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2181414 | camphor 32 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2181415 | camphor 3.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2181415 | camphor 3.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2181415 | camphor 3.2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2181419 | Brucine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2181419 | Brucine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2181419 | Brucine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218143 | MB-TAB | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218147 | MG 217 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218148 | MG 217 Psoriasis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218151 | MY-E | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218152 | MZM | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2181523 | asparaginase Erwinia chrysanthemi 10000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2181524 | asparaginase Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2181526 | asparaginase Erwinia chrysanthemi 10000 UNT [Erwinaze] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2181527 | asparaginase Injection [Erwinaze] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 218153 | Maalox Anti-Diarrheal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2181533 | Selenicereus undatus fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2181533 | Selenicereus undatus fruit extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2181534 | methicillin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2181535 | methicillin Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 218154 | Maalox Anti-Gas | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218155 | Maalox Anti-Gas Extra Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218160 | Mag 64 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218161 | Mag-200 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218163 | Mag-G | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218164 | Mag-Tab | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218165 | Magaant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218166 | Magagel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218167 | Magagel Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218169 | Magalox Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 21817 | Cytosine triphosphate (CTP) synthase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21817 | Cytosine triphosphate (CTP) synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 21817 | Cytosine triphosphate (CTP) synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 21817 | Cytosine triphosphate (CTP) synthase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 21817 | Cytosine triphosphate (CTP) synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 218170 | Magan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218173 | Magnalox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218174 | Magnaprin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218175 | Magnebind-200 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218176 | Magnebind-300 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218181 | Magonate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218183 | Magsal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218184 | Magtrate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218187 | Major-Cin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218189 | Major-gesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218190 | Majorcon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218191 | Malatal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218194 | Maldroxal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218195 | Maldroxal Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218196 | Mallazine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218197 | Mallisol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218198 | Mallopress | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218199 | Mallotuss | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2182 | Cefmetazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2182 | Cefmetazole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2182 | Cefmetazole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2182 | Cefmetazole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2182 | Cefmetazole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 21820 | Cucumisin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21820 | Cucumisin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218202 | Mantadil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218203 | Maolate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218204 | Maoson | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218205 | Mapap | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218207 | Mapap Junior Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218208 | Mapap PM | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218210 | Mar-Zinc | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218211 | Marax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218213 | Marblen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218217 | Marcillin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218218 | Marcof Expectorant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218219 | Mardol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218220 | Margesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218221 | Margesic #3 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218222 | Margesic-H | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218226 | Marpres | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218227 | Marten-Tab | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218228 | Marthritic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218229 | Masanti | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 21823 | Cucurbitacin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21823 | Cucurbitacin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218232 | Masophen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218233 | Masophen PM | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2182337 | etanercept Cartridge | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2182338 | etanercept 50 MG in 1 mL Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2182338 | etanercept 50 MG in 1 mL Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2182338 | etanercept 50 MG in 1 mL Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2182339 | etanercept Cartridge [Enbrel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 218234 | Masporin Otic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2182340 | Enbrel 50 MG in 1 mL Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2182340 | Enbrel 50 MG in 1 mL Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2182340 | Enbrel 50 MG in 1 mL Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2182340 | Enbrel 50 MG in 1 mL Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2182341 | etanercept 50 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2182342 | etanercept 50 MG/ML Cartridge [Enbrel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2182342 | etanercept 50 MG/ML Cartridge [Enbrel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2182346 | chlorpheniramine maleate 1 MG / pseudoephedrine HCl 15 MG per 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2182346 | chlorpheniramine maleate 1 MG / pseudoephedrine HCl 15 MG per 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2182346 | chlorpheniramine maleate 1 MG / pseudoephedrine HCl 15 MG per 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2182349 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2182349 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 218235 | Massengill Medicated Douche | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2182350 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML [MINTUSS HC Reformulated Feb 2009] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2182350 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML [MINTUSS HC Reformulated Feb 2009] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2182351 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution [MINTUSS HC Reformulated Feb 2009] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2182351 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution [MINTUSS HC Reformulated Feb 2009] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2182351 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution [MINTUSS HC Reformulated Feb 2009] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2182351 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution [MINTUSS HC Reformulated Feb 2009] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2182352 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML [De-Chlor HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2182352 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML [De-Chlor HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2182353 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution [De-Chlor HC] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2182353 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution [De-Chlor HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2182353 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution [De-Chlor HC] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2182353 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution [De-Chlor HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2182354 | chlorpheniramine maleate 0.5 MG/ML / hydrocodone bitartrate 0.65 MG/ML / phenylephrine hydrochloride 1.6 MG/ML [Relasin HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2182354 | chlorpheniramine maleate 0.5 MG/ML / hydrocodone bitartrate 0.65 MG/ML / phenylephrine hydrochloride 1.6 MG/ML [Relasin HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2182355 | chlorpheniramine maleate 0.5 MG/ML / hydrocodone bitartrate 0.65 MG/ML / phenylephrine hydrochloride 1.6 MG/ML Oral Solution [Relasin HC] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2182355 | chlorpheniramine maleate 0.5 MG/ML / hydrocodone bitartrate 0.65 MG/ML / phenylephrine hydrochloride 1.6 MG/ML Oral Solution [Relasin HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2182355 | chlorpheniramine maleate 0.5 MG/ML / hydrocodone bitartrate 0.65 MG/ML / phenylephrine hydrochloride 1.6 MG/ML Oral Solution [Relasin HC] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2182355 | chlorpheniramine maleate 0.5 MG/ML / hydrocodone bitartrate 0.65 MG/ML / phenylephrine hydrochloride 1.6 MG/ML Oral Solution [Relasin HC] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 218237 | Mastussin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2182390 | Quellaxcin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2182391 | enrofloxacin 100 MG/ML [Quellaxcin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2182392 | enrofloxacin Injectable Solution [Quellaxcin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2182393 | Quellaxcin Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2182394 | Quellaxcin 100 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2182394 | Quellaxcin 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2182394 | Quellaxcin 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2182395 | Enromed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2182396 | enrofloxacin 100 MG/ML [Enromed] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2182397 | enrofloxacin Injectable Solution [Enromed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2182398 | Enromed Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2182399 | EnroMed 100 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2182399 | EnroMed 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2182399 | EnroMed 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 218245 | Mavik | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218246 | Maxair | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218248 | Maxalt | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218250 | Maxaquin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218252 | Maxi-Tuss HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218253 | Maxi-Tuss SA | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218256 | Maxiflor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218260 | Stress Maximum Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218262 | Maxivate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218264 | Mebaral | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218265 | Meclicot | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218266 | Med Aspirin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218268 | Med-Hist Expectorant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218269 | Med-Hist-HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 21827 | Cumene | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21827 | Cumene | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218272 | Meda Cap | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218273 | Medasulf | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218274 | Medcodin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218276 | Medent C | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218278 | Mederek | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2182794 | polyethyloxazoline (500000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2182796 | mannitol 300 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2182797 | mannitol / menthol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2182798 | mannitol / menthol Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2182799 | mannitol / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2182800 | mannitol 30 % / menthol 1.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2182800 | mannitol 30 % / menthol 1.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2182800 | mannitol 30 % / menthol 1.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 218282 | Medicated Blue | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218285 | Medicort | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218289 | Medigesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2182890 | sodium lauroyl methylaminopropionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2182891 | lauroyl methylaminoproprionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 218290 | Medilax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218291 | Medipain 5 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218294 | Meditest | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218295 | Medivert | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218299 | Medtuss HD | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183 | Cefonicid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2183 | Cefonicid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183 | Cefonicid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183 | Cefonicid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183 | Cefonicid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218302 | Melanex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218303 | Melanol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218304 | Mellaril-S | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218305 | Melpaque HP | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218306 | Melquin HP | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218307 | Melquin-3 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218308 | Menadol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218309 | Menest | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218310 | Meni-D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183100 | Dibutyltin dilaurate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2183100 | Dibutyltin dilaurate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2183100 | Dibutyltin dilaurate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2183101 | dibutyltin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2183102 | pexidartinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2183102 | pexidartinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2183102 | pexidartinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2183102 | pexidartinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2183102 | pexidartinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2183103 | pexidartinib hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 218311 | Menogen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183121 | pexidartinib 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2183122 | pexidartinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2183122 | pexidartinib Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2183122 | pexidartinib Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2183123 | pexidartinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2183124 | pexidartinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2183125 | pexidartinib 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2183125 | pexidartinib 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2183125 | pexidartinib 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2183126 | Turalio | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2183127 | pexidartinib 200 MG [Turalio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2183128 | pexidartinib Oral Capsule [Turalio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2183129 | Turalio Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 218313 | Menomune A/C/Y/W-135 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183130 | Turalio Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2183131 | Turalio 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2183131 | Turalio 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2183131 | Turalio 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2183131 | Turalio 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 218315 | Mentax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218316 | Menthac Arthritis Cream with Capsaicin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2183190 | Ampicillin and sulbactam only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183190 | Ampicillin and sulbactam only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183191 | Calcium electrolyte and colecalciferol only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183191 | Calcium electrolyte and colecalciferol only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183191 | Calcium electrolyte and colecalciferol only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183192 | Calcium electrolyte and colecalciferol only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183192 | Calcium electrolyte and colecalciferol only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183192 | Calcium electrolyte and colecalciferol only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183193 | Calcium phosphate and carmellose only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183193 | Calcium phosphate and carmellose only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183193 | Calcium phosphate and carmellose only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183194 | Calcium phosphate only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183194 | Calcium phosphate only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183195 | Camphor and menthol and methyl salicylate only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183195 | Camphor and menthol and methyl salicylate only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183198 | Carbachol only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183198 | Carbachol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183199 | Carbenoxolone only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183199 | Carbenoxolone only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183200 | Degarelix only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183200 | Degarelix only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183201 | Denosumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183201 | Denosumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183202 | Dexamethasone and hypromellose only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183202 | Dexamethasone and hypromellose only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183203 | Dexamethasone and hypromellose only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183203 | Dexamethasone and hypromellose only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183204 | Goserelin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183204 | Goserelin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183206 | Halobetasol and tazarotene only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183206 | Halobetasol and tazarotene only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183207 | Product containing only halobetasol and tazarotene in cutaneous dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183207 | Product containing only halobetasol and tazarotene in cutaneous dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183208 | Halobetasol only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183208 | Halobetasol only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183209 | Isophane insulin and porcine insulin soluble only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183209 | Isophane insulin and porcine insulin soluble only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183209 | Isophane insulin and porcine insulin soluble only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183210 | Isophane insulin and porcine insulin soluble only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183210 | Isophane insulin and porcine insulin soluble only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183210 | Isophane insulin and porcine insulin soluble only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183211 | Isophane insulin and recombinant human soluble insulin only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183211 | Isophane insulin and recombinant human soluble insulin only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183211 | Isophane insulin and recombinant human soluble insulin only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183212 | Isophane insulin and recombinant human soluble insulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183212 | Isophane insulin and recombinant human soluble insulin only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183212 | Isophane insulin and recombinant human soluble insulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183213 | Ixabepilone only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183213 | Ixabepilone only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183214 | Nystatin only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183214 | Nystatin only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183215 | Olanzapine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183215 | Olanzapine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183216 | Amylase and endopeptidase and pancreatic lipase only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183216 | Amylase and endopeptidase and pancreatic lipase only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183217 | Amylase and endopeptidase and pancreatic lipase only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183217 | Amylase and endopeptidase and pancreatic lipase only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183218 | Amylase and endopeptidase and triacylglycerol lipase only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183218 | Amylase and endopeptidase and triacylglycerol lipase only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183219 | Amylase and endopeptidase and triacylglycerol lipase only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183219 | Amylase and endopeptidase and triacylglycerol lipase only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218322 | Mepergan Fortis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183220 | Anakinra only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183220 | Anakinra only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183221 | Andexanet alfa only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183221 | Andexanet alfa only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183222 | Andexanet alfa only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183222 | Andexanet alfa only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183223 | Anidulafungin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183223 | Anidulafungin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183224 | Anthraquinone glycoside and salicylic acid only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183224 | Anthraquinone glycoside and salicylic acid only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183225 | Anthraquinone glycoside and salicylic acid only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183225 | Anthraquinone glycoside and salicylic acid only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183226 | Carbidopa and levodopa only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183226 | Carbidopa and levodopa only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183227 | Carbinoxamine and dextromethorphan and pseudoephedrine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183227 | Carbinoxamine and dextromethorphan and pseudoephedrine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183228 | Carmellose and hydroxyapatite only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183228 | Carmellose and hydroxyapatite only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183228 | Carmellose and hydroxyapatite only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183229 | Carmellose and hydroxyapatite only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183229 | Carmellose and hydroxyapatite only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183229 | Carmellose and hydroxyapatite only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183230 | Carmellose only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183230 | Carmellose only product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183230 | Carmellose only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183231 | Carmellose only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183231 | Carmellose only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183231 | Carmellose only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183232 | Carglumic acid only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183232 | Carglumic acid only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183233 | Dexlansoprazole only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183233 | Dexlansoprazole only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183234 | Dextran 40 only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183234 | Dextran 40 only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183235 | Dextran 40 only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183235 | Dextran 40 only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183236 | Dextromethorphan and guaifenesin only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183236 | Dextromethorphan and guaifenesin only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183237 | Dextromethorphan and promethazine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183237 | Dextromethorphan and promethazine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183238 | Dextromethorphan only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183238 | Dextromethorphan only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183239 | Amidotrizoate only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183239 | Amidotrizoate only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183239 | Amidotrizoate only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218324 | Mephyton | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2183240 | Dibromosalicylanilide only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183240 | Dibromosalicylanilide only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183241 | Cinchocaine and prednisolone only product in rectal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183241 | Cinchocaine and prednisolone only product in rectal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183241 | Cinchocaine and prednisolone only product in rectal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183242 | Hepatitis B surface antigen immunoglobulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183242 | Hepatitis B surface antigen immunoglobulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183243 | Hetastarch only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183243 | Hetastarch only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183244 | Hexachlorophene only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183244 | Hexachlorophene only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183245 | Human C1 esterase inhibitor only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183245 | Human C1 esterase inhibitor only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183246 | Human C1 esterase inhibitor only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183246 | Human C1 esterase inhibitor only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183247 | Human alpha1 proteinase inhibitor only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183247 | Human alpha1 proteinase inhibitor only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183248 | Human alpha1 proteinase inhibitor only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183248 | Human alpha1 proteinase inhibitor only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183249 | Human anti-D immunoglobulin only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183249 | Human anti-D immunoglobulin only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218325 | Meprozine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183250 | Human anti-D immunoglobulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183250 | Human anti-D immunoglobulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183251 | Human chorionic gonadotropin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183251 | Human chorionic gonadotropin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183252 | Product containing only propamidine in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183252 | Product containing only propamidine in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183253 | Proxymetacaine only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183253 | Proxymetacaine only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183253 | Proxymetacaine only product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183254 | Carmustine only product in prolonged-release intralesional implant | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183254 | Carmustine only product in prolonged-release intralesional implant | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183255 | Diethylstilbestrol only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183255 | Diethylstilbestrol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183256 | Difluprednate only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183256 | Difluprednate only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183257 | Dihydroergotamine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183257 | Dihydroergotamine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183258 | Dihydroergotamine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183258 | Dihydroergotamine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183259 | Diphenhydramine and zinc acetate only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183259 | Diphenhydramine and zinc acetate only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218326 | Mericaine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183260 | Human immunoglobulin G only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183260 | Human immunoglobulin G only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183261 | Human protein C only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183261 | Human protein C only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183262 | Human protein C only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183262 | Human protein C only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183263 | Lamivudine and nevirapine and stavudine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183263 | Lamivudine and nevirapine and stavudine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183264 | Product containing only rabbit anti-human T-lymphocyte globulin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183264 | Product containing only rabbit anti-human T-lymphocyte globulin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183265 | Product containing only ranibizumab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183265 | Product containing only ranibizumab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183266 | Product containing only ravulizumab (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183266 | Product containing only ravulizumab (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183267 | Product containing only ravulizumab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183267 | Product containing only ravulizumab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183268 | Product containing only recombinant coagulation factor IX in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183268 | Product containing only recombinant coagulation factor IX in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183269 | Docosanol only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183269 | Docosanol only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218327 | Meritate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183270 | Dolutegravir and lamivudine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183270 | Dolutegravir and lamivudine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183271 | Dolutegravir and lamivudine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183271 | Dolutegravir and lamivudine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183272 | Donepezil only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183272 | Donepezil only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183273 | Dornase alfa only product in pulmonary dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183273 | Dornase alfa only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183274 | Diiodohydroxyquinoline and hydrocortisone only product in cutaneous dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183274 | Diiodohydroxyquinoline and hydrocortisone only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183274 | Diiodohydroxyquinoline and hydrocortisone only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183275 | Hydrocortisone and neomycin only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183275 | Hydrocortisone and neomycin only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183276 | Hydrocortisone and neomycin only product in otic dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183276 | Hydrocortisone and neomycin only product in otic dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183277 | Hydrocortisone and pramocaine only product in cutaneous dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183277 | Hydrocortisone and pramocaine only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183277 | Hydrocortisone and pramocaine only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183278 | Hydroxyamfetamine and tropicamide only product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183278 | Hydroxyamfetamine and tropicamide only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183278 | Hydroxyamfetamine and tropicamide only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183279 | Hydroxyapatite only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183279 | Hydroxyapatite only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183279 | Hydroxyapatite only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218328 | Mersol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183280 | Lamotrigine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183280 | Lamotrigine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183281 | Lanolin and zinc oxide only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183281 | Lanolin and zinc oxide only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183282 | Lanolin and zinc oxide only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183282 | Lanolin and zinc oxide only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183283 | Lansoprazole only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183283 | Lansoprazole only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183284 | Lanthanum carbonate only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183284 | Lanthanum carbonate only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183285 | Lanthanum carbonate only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183285 | Lanthanum carbonate only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183286 | Larotrectinib only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183286 | Larotrectinib only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183287 | Larotrectinib only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183287 | Larotrectinib only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183288 | Oxybutynin only product in transdermal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183288 | Oxybutynin only product in transdermal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183290 | Palifermin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183290 | Palifermin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183291 | Paliperidone only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183291 | Paliperidone only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183292 | Pegvisomant only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183292 | Pegvisomant only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183293 | Pemetrexed only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183293 | Pemetrexed only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183294 | Pemirolast only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183294 | Pemirolast only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183295 | Benzylpenicillin only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183295 | Benzylpenicillin only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183295 | Benzylpenicillin only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183296 | Product containing only siltuximab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183296 | Product containing only siltuximab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183297 | Product containing only simvastatin in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183297 | Product containing only simvastatin in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183298 | Product containing only siponimod (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183298 | Product containing only siponimod (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183299 | Product containing only siponimod in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183299 | Product containing only siponimod in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21833 | cupric chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 218330 | Mesnex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2183300 | Product containing only sodium benzoate and sodium phenylacetate in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183300 | Product containing only sodium benzoate and sodium phenylacetate in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183301 | Product containing only sodium chloride in conventional release solution for irrigation (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183301 | Product containing only sodium chloride in conventional release solution for irrigation (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183302 | Certolizumab pegol only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183302 | Certolizumab pegol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183303 | Cetirizine and pseudoephedrine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183303 | Cetirizine and pseudoephedrine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183304 | Cetirizine and pseudoephedrine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183304 | Cetirizine and pseudoephedrine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183305 | Cetyl alcohol and colfosceril and tyloxapol only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183305 | Cetyl alcohol and colfosceril and tyloxapol only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183306 | Cetyl dimeticone only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183306 | Cetyl dimeticone only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183306 | Cetyl dimeticone only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183307 | Cetyl dimeticone only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183307 | Cetyl dimeticone only product in cutaneous dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183307 | Cetyl dimeticone only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218331 | Metahistine D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183311 | Hydroxyapatite only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183311 | Hydroxyapatite only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183311 | Hydroxyapatite only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183314 | Levomethadyl only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183314 | Levomethadyl only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183315 | Corbadrine and mepivacaine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183315 | Corbadrine and mepivacaine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183315 | Corbadrine and mepivacaine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183316 | Corbadrine and mepivacaine only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183316 | Corbadrine and mepivacaine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183316 | Corbadrine and mepivacaine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183318 | Levosimendan only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183318 | Levosimendan only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183319 | Para-aminohippuric acid only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183319 | Para-aminohippuric acid only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218332 | Metahydrin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183320 | Para-aminohippuric acid only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183320 | Para-aminohippuric acid only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183321 | Pegaptanib only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183321 | Pegaptanib only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183322 | Pentastarch only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183322 | Pentastarch only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183323 | Phenylalanine ammonia-lyase only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183323 | Phenylalanine ammonia-lyase only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183324 | Phenylalanine ammonia-lyase only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183324 | Phenylalanine ammonia-lyase only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183325 | Phenylbutyric acid only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183325 | Phenylbutyric acid only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183326 | Phenylbutyric acid only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183326 | Phenylbutyric acid only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183327 | Product containing only recombinant human antithrombin III in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183327 | Product containing only recombinant human antithrombin III in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183328 | Product containing only revefenacin (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183328 | Product containing only revefenacin (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183329 | Product containing only revefenacin in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183329 | Product containing only revefenacin in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183330 | Product containing only rifamycin (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183330 | Product containing only rifamycin (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183331 | Product containing only rifamycin in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183331 | Product containing only rifamycin in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183332 | Product containing only rilonacept in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183332 | Product containing only rilonacept in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183333 | Product containing only rimabotulinumtoxinB (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183333 | Product containing only rimabotulinumtoxinB (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183334 | Product containing only rimabotulinumtoxinB in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183334 | Product containing only rimabotulinumtoxinB in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183335 | Product containing only risankizumab (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183335 | Product containing only risankizumab (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183336 | Product containing only risankizumab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183336 | Product containing only risankizumab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183337 | Chlorhexidine and sodium nitrite only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183337 | Chlorhexidine and sodium nitrite only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183338 | Chlorhexidine and sodium nitrite only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183338 | Chlorhexidine and sodium nitrite only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183340 | Chloroxine only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183340 | Chloroxine only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183341 | Chlorphenamine and ibuprofen and pseudoephedrine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183341 | Chlorphenamine and ibuprofen and pseudoephedrine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183341 | Chlorphenamine and ibuprofen and pseudoephedrine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183342 | Chlorphenamine and methscopolamine and pseudoephedrine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183342 | Chlorphenamine and methscopolamine and pseudoephedrine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183342 | Chlorphenamine and methscopolamine and pseudoephedrine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183343 | Chlorphenamine and methscopolamine and pseudoephedrine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183343 | Chlorphenamine and methscopolamine and pseudoephedrine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183343 | Chlorphenamine and methscopolamine and pseudoephedrine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183344 | Drospirenone and ethinylestradiol and levomefolic acid only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183344 | Drospirenone and ethinylestradiol and levomefolic acid only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183344 | Drospirenone and ethinylestradiol and levomefolic acid only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183345 | Drospirenone and ethinylestradiol and levomefolic acid only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183345 | Drospirenone and ethinylestradiol and levomefolic acid only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183345 | Drospirenone and ethinylestradiol and levomefolic acid only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183346 | Lidocaine and prilocaine only product in dental dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183346 | Lidocaine and prilocaine only product in dental dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183347 | Linaclotide only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183347 | Linaclotide only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183348 | Lisdexamfetamine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183348 | Lisdexamfetamine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183349 | Lisdexamfetamine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183349 | Lisdexamfetamine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218335 | Meted | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183350 | Loratadine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183350 | Loratadine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183351 | Phosphorus-32 only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183351 | Phosphorus-32 only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183352 | Physostigmine and pilocarpine only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183352 | Physostigmine and pilocarpine only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183353 | Piperacillin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183353 | Piperacillin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183354 | Caffeine and isometheptene and paracetamol only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183354 | Caffeine and isometheptene and paracetamol only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183354 | Caffeine and isometheptene and paracetamol only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183355 | Chlorphenamine and paracetamol and phenylephrine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183355 | Chlorphenamine and paracetamol and phenylephrine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183355 | Chlorphenamine and paracetamol and phenylephrine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183356 | Paracetamol and pentazocine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183356 | Paracetamol and pentazocine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183356 | Paracetamol and pentazocine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183357 | Paracetamol and pentazocine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183357 | Paracetamol and pentazocine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183357 | Paracetamol and pentazocine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183358 | Paracetamol and promethazine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183358 | Paracetamol and promethazine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183358 | Paracetamol and promethazine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183359 | Paracetamol and promethazine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183359 | Paracetamol and promethazine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183359 | Paracetamol and promethazine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218336 | Methadex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183360 | Paracetamol only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183360 | Paracetamol only product in oromucosal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183360 | Paracetamol only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183361 | Acetic acid and hydrocortisone only product in otic dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183361 | Acetic acid and hydrocortisone only product in otic dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183362 | Acetic acid and oxyquinoline only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183362 | Acetic acid and oxyquinoline only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183363 | Acetic acid and oxyquinoline only product in vaginal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183363 | Acetic acid and oxyquinoline only product in vaginal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183364 | Acetic acid only product in solution for irrigation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183364 | Acetic acid only product in solution for irrigation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183365 | Acetylcholine only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183365 | Acetylcholine only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183366 | Acetylcholine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183366 | Acetylcholine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183367 | Product containing only risperidone in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183367 | Product containing only risperidone in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183368 | Product containing only rizatriptan in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183368 | Product containing only rizatriptan in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183369 | Product containing only romidepsin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183369 | Product containing only romidepsin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 218337 | Methadone hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 218337 | Methadone hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 218337 | Methadone hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2183370 | Product containing only romosozumab (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183370 | Product containing only romosozumab (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183371 | Product containing only romosozumab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183371 | Product containing only romosozumab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183372 | Product containing only sacrosidase in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183372 | Product containing only sacrosidase in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183373 | Product containing only salicylic acid and sulfur in cutaneous dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183373 | Product containing only salicylic acid and sulfur in cutaneous dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183374 | Chlorphenamine and phenylephrine and phenyltoloxamine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183374 | Chlorphenamine and phenylephrine and phenyltoloxamine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183374 | Chlorphenamine and phenylephrine and phenyltoloxamine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183375 | Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183375 | Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183375 | Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183376 | Colestyramine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183376 | Colestyramine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183376 | Colestyramine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183377 | Droxidopa only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183377 | Droxidopa only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183378 | Dyclonine only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183378 | Dyclonine only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183379 | Ecallantide only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183379 | Ecallantide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183380 | Efinaconazole only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183380 | Efinaconazole only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183381 | Lorlatinib only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183381 | Lorlatinib only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183382 | Lorlatinib only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183382 | Lorlatinib only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183383 | Loteprednol and tobramycin only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183383 | Loteprednol and tobramycin only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183384 | Lutropin alfa only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183384 | Lutropin alfa only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183385 | Mafenide only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183385 | Mafenide only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183386 | Magnesium citrate only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183386 | Magnesium citrate only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183387 | Magnesium hydroxide and omeprazole and sodium bicarbonate only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183387 | Magnesium hydroxide and omeprazole and sodium bicarbonate only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183388 | Pituitary follicle stimulating hormone and pituitary luteinizing hormone only product | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2183388 | Pituitary follicle stimulating hormone and pituitary luteinizing hormone only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183388 | Pituitary follicle stimulating hormone and pituitary luteinizing hormone only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183389 | Pituitary follicle stimulating hormone and pituitary luteinizing hormone only product in parenteral dose form | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2183389 | Pituitary follicle stimulating hormone and pituitary luteinizing hormone only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183389 | Pituitary follicle stimulating hormone and pituitary luteinizing hormone only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183390 | Plerixafor only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183390 | Plerixafor only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183391 | Plicamycin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183391 | Plicamycin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183392 | Poloxamer 188 only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183392 | Poloxamer 188 only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183393 | Poloxamer 188 only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183393 | Poloxamer 188 only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183394 | Macrogol 3350 only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183394 | Macrogol 3350 only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183394 | Macrogol 3350 only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183395 | Macrogol only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183395 | Macrogol only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183395 | Macrogol only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183396 | Aclarubicin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183396 | Aclarubicin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183397 | Aclidinium and formoterol only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183397 | Aclidinium and formoterol only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183398 | Aclidinium and formoterol only product in pulmonary dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183398 | Aclidinium and formoterol only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183399 | Product containing only salicylic acid and zinc oxide in cutaneous dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183399 | Product containing only salicylic acid and zinc oxide in cutaneous dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183400 | Product containing only salmon calcitonin in nasal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183400 | Product containing only salmon calcitonin in nasal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183401 | Product containing only selegiline in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183401 | Product containing only selegiline in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183402 | Choline and glycerol only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183402 | Choline and glycerol only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183402 | Choline and glycerol only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183403 | Choline and glycerol only product in otic dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183403 | Choline and glycerol only product in otic dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183403 | Choline and glycerol only product in otic dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183404 | Chromic phosphate (32-P) only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183404 | Chromic phosphate (32-P) only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183405 | Chromic phosphate (32-P) only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183405 | Chromic phosphate (32-P) only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183406 | Emapalumab only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183406 | Emapalumab only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183407 | Emapalumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183407 | Emapalumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183408 | Enalapril and felodipine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183408 | Enalapril and felodipine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183409 | Enalapril and felodipine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183409 | Enalapril and felodipine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183410 | Encorafenib only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183410 | Encorafenib only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183411 | Enfuvirtide only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183411 | Enfuvirtide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183412 | Mandelic acid only product in solution for irrigation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183412 | Mandelic acid only product in solution for irrigation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183413 | Mangafodipir only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183413 | Mangafodipir only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183414 | Mangafodipir only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183414 | Mangafodipir only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183415 | Meclozine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183415 | Meclozine only product in oromucosal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183415 | Meclozine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183416 | Polythiazide and prazosin only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183416 | Polythiazide and prazosin only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183417 | Polythiazide and prazosin only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183417 | Polythiazide and prazosin only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218342 | Metimyd | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183420 | Potassium gluconate only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183420 | Potassium gluconate only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183421 | Albiglutide only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183421 | Albiglutide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183422 | Ipratropium and salbutamol only product in pulmonary dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183422 | Ipratropium and salbutamol only product in pulmonary dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183422 | Ipratropium and salbutamol only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183423 | Alcaftadine only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183423 | Alcaftadine only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183424 | Antidiuretic hormone only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183424 | Antidiuretic hormone only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183425 | Antimonic acid only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183425 | Antimonic acid only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183426 | Antimonic acid only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183426 | Antimonic acid only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183427 | Aripiprazole only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183427 | Aripiprazole only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183428 | Adrenaline and articaine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183428 | Adrenaline and articaine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183428 | Adrenaline and articaine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183429 | Adrenaline and articaine only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183429 | Adrenaline and articaine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183429 | Adrenaline and articaine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218343 | MetroCream | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2183430 | Asenapine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183430 | Asenapine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183431 | Ciprofloxacin and dexamethasone only product in otic dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183431 | Ciprofloxacin and dexamethasone only product in otic dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183432 | Citalopram only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183432 | Citalopram only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183433 | Citric acid and potassium bicarbonate only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183433 | Citric acid and potassium bicarbonate only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183434 | Citric acid and potassium bicarbonate only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183434 | Citric acid and potassium bicarbonate only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183435 | Citric acid and potassium citrate and sodium citrate only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183435 | Citric acid and potassium citrate and sodium citrate only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183436 | Citric acid and potassium citrate and sodium citrate only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183436 | Citric acid and potassium citrate and sodium citrate only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183437 | Cladribine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183437 | Cladribine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183438 | Adrenaline and etidocaine only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183438 | Adrenaline and etidocaine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183438 | Adrenaline and etidocaine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183439 | Adrenaline and lidocaine only product in cutaneous dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183439 | Adrenaline and lidocaine only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183439 | Adrenaline and lidocaine only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183440 | Adrenaline and mepivacaine only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183440 | Adrenaline and mepivacaine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183440 | Adrenaline and mepivacaine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183441 | Adrenaline and prilocaine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183441 | Adrenaline and prilocaine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183441 | Adrenaline and prilocaine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183442 | Adrenaline and prilocaine only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183442 | Adrenaline and prilocaine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183442 | Adrenaline and prilocaine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183443 | Equine antithymocyte immunoglobulin only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183443 | Equine antithymocyte immunoglobulin only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183444 | Equine antithymocyte immunoglobulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183444 | Equine antithymocyte immunoglobulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183445 | Erdafitinib only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183445 | Erdafitinib only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183446 | Erdafitinib only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183446 | Erdafitinib only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183447 | Ertapenem only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183447 | Ertapenem only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183448 | Imiquimod only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183448 | Imiquimod only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183449 | Prednicarbate only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183449 | Prednicarbate only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218345 | MetroLotion | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2183450 | Prednisolone and sulfacetamide only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183450 | Prednisolone and sulfacetamide only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183451 | Prednisolone and sulfacetamide only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183451 | Prednisolone and sulfacetamide only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183452 | Prednisolone only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183452 | Prednisolone only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183453 | Prednisolone only product in otic dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183453 | Prednisolone only product in otic dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183454 | Aldesleukin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183454 | Aldesleukin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183455 | Alglucerase only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183455 | Alglucerase only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183456 | Aliskiren and amlodipine and hydrochlorothiazide only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183456 | Aliskiren and amlodipine and hydrochlorothiazide only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183457 | Alprazolam only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183457 | Alprazolam only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183458 | Aspirin and glycine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183458 | Aspirin and glycine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183459 | Aspirin only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183459 | Aspirin only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218346 | Metryl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183460 | Aztreonam only product in pulmonary dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183460 | Aztreonam only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183461 | Baclofen only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183461 | Baclofen only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183464 | Clindamycin and tretinoin only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183464 | Clindamycin and tretinoin only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183465 | Clocortolone only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183465 | Clocortolone only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183466 | Clonazepam only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183466 | Clonazepam only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183467 | Clopenthixol only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183467 | Clopenthixol only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183468 | Clopenthixol only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183468 | Clopenthixol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183469 | Clostridium histolyticum collagenase only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183469 | Clostridium histolyticum collagenase only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183470 | Clostridium histolyticum collagenase only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183470 | Clostridium histolyticum collagenase only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183471 | Esterified estrogen and methyltestosterone only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183471 | Esterified estrogen and methyltestosterone only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183472 | Melatonin only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183472 | Melatonin only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183473 | Procaine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183473 | Procaine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183474 | Aluminium acetate only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183474 | Aluminium acetate only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183474 | Aluminium acetate only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183475 | Aluminium acetate only product in cutaneous dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183475 | Aluminium acetate only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183475 | Aluminium acetate only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183476 | Aluminium acetate only product in otic dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183476 | Aluminium acetate only product in otic dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183476 | Aluminium acetate only product in otic dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183477 | Amifampridine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183477 | Amifampridine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183478 | Amifampridine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183478 | Amifampridine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183479 | Barium sulfate only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183479 | Barium sulfate only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218348 | Mi-Acid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2183480 | Belinostat only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183480 | Belinostat only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183481 | Belladonna alkaloid and opium only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183481 | Belladonna alkaloid and opium only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183482 | Belladonna alkaloid and opium only product in rectal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183482 | Belladonna alkaloid and opium only product in rectal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183483 | Fluorescein stain and oxybuprocaine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183483 | Fluorescein stain and oxybuprocaine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183483 | Fluorescein stain and oxybuprocaine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183484 | Fluorescein stain and oxybuprocaine only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183484 | Fluorescein stain and oxybuprocaine only product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183484 | Fluorescein stain and oxybuprocaine only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183485 | Benserazide and levodopa only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183485 | Benserazide and levodopa only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183486 | Bentoquatam only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183486 | Bentoquatam only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183487 | Benzalkonium and polyethylene only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183487 | Benzalkonium and polyethylene only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183488 | Benzalkonium and polyethylene only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183488 | Benzalkonium and polyethylene only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183489 | Coagulation factor VIII and von Willebrand factor only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183489 | Coagulation factor VIII and von Willebrand factor only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183490 | Coal tar and lecithin only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183490 | Coal tar and lecithin only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183491 | Coal tar and pine tar only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183491 | Coal tar and pine tar only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183492 | Coal tar and pine tar only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183492 | Coal tar and pine tar only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183493 | Cobalt chloride only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183493 | Cobalt chloride only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183494 | Cobalt chloride only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183494 | Cobalt chloride only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183495 | Adrenaline and cocaine only product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183495 | Adrenaline and cocaine only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183495 | Adrenaline and cocaine only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183496 | Cocaine and homatropine only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183496 | Cocaine and homatropine only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183497 | Cocaine only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183497 | Cocaine only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183499 | Estrone only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183499 | Estrone only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183500 | Estrone only product in vaginal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183500 | Estrone only product in vaginal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183501 | Estropipate only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183501 | Estropipate only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183502 | Estropipate only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183502 | Estropipate only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183503 | Estropipate only product in vaginal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183503 | Estropipate only product in vaginal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183504 | Etacrynic acid only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183504 | Etacrynic acid only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183504 | Etacrynic acid only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183505 | Ethinylestradiol and ferrous fumarate and norethisterone only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183505 | Ethinylestradiol and ferrous fumarate and norethisterone only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183505 | Ethinylestradiol and ferrous fumarate and norethisterone only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183507 | Menthol and methyl salicylate only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183507 | Menthol and methyl salicylate only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183508 | Meptazinol only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183508 | Meptazinol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183509 | Mequinol and tretinoin only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183509 | Mequinol and tretinoin only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218351 | Miacalcin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2183510 | Metformin and saxagliptin only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183510 | Metformin and saxagliptin only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183511 | Metformin and saxagliptin only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183511 | Metformin and saxagliptin only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183512 | Benzocaine and trimethobenzamide only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183512 | Benzocaine and trimethobenzamide only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183513 | Benzocaine and trimethobenzamide only product in rectal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183513 | Benzocaine and trimethobenzamide only product in rectal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183514 | Benzquinamide only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183514 | Benzquinamide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183515 | Benzyl alcohol only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183515 | Benzyl alcohol only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183516 | Bepotastine only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183516 | Bepotastine only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183517 | Codeine and kaolin only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183517 | Codeine and kaolin only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183518 | Codeine and phenylephrine and promethazine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183518 | Codeine and phenylephrine and promethazine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183519 | Codeine and promethazine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183519 | Codeine and promethazine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183520 | Codeine and promethazine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183520 | Codeine and promethazine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183521 | Conjugated estrogen and esterified estrogen and medroxyprogesterone only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183521 | Conjugated estrogen and esterified estrogen and medroxyprogesterone only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183522 | Conjugated estrogen and esterified estrogen and medroxyprogesterone only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183522 | Conjugated estrogen and esterified estrogen and medroxyprogesterone only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183523 | Crisantaspase only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183523 | Crisantaspase only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183524 | Etidocaine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183524 | Etidocaine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183526 | Famotidine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183526 | Famotidine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183527 | Fenoterol and ipratropium only product in pulmonary dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183527 | Fenoterol and ipratropium only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183528 | Fentanyl only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183528 | Fentanyl only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183529 | Metoclopramide only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183529 | Metoclopramide only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218353 | Micardis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2183530 | Betamethasone and calcipotriol only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183530 | Betamethasone and calcipotriol only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183531 | Betamethasone and neomycin only product in nasal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183531 | Betamethasone and neomycin only product in nasal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183532 | Betamethasone and neomycin only product in otic dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183532 | Betamethasone and neomycin only product in otic dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183533 | Betamethasone only product in nasal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183533 | Betamethasone only product in nasal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183534 | Betamethasone only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183534 | Betamethasone only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183535 | Betamethasone only product in otic dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183535 | Betamethasone only product in otic dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183536 | Boric acid and salicylic acid only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183536 | Boric acid and salicylic acid only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183537 | Boric acid and salicylic acid only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183537 | Boric acid and salicylic acid only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183538 | Botulism immunoglobulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183538 | Botulism immunoglobulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183539 | Cyanocobalamin (57-Co) only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183539 | Cyanocobalamin (57-Co) only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218354 | Micatin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2183540 | Cyanocobalamin (57-Co) only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183540 | Cyanocobalamin (57-Co) only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183541 | Cyanocobalamin (58-Co) only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183541 | Cyanocobalamin (58-Co) only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183542 | Cyanocobalamin (58-Co) only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183542 | Cyanocobalamin (58-Co) only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183543 | Cyclopentolate and phenylephrine only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183543 | Cyclopentolate and phenylephrine only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183544 | Fluocinolone and hydroquinone and tretinoin only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183544 | Fluocinolone and hydroquinone and tretinoin only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183545 | Fluorescein stain and proxymetacaine only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183545 | Fluorescein stain and proxymetacaine only product in ocular dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183545 | Fluorescein stain and proxymetacaine only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183546 | Mezlocillin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183546 | Mezlocillin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183547 | Miconazole and zinc oxide only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183547 | Miconazole and zinc oxide only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183548 | Miconazole and zinc oxide only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183548 | Miconazole and zinc oxide only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183549 | Miconazole only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183549 | Miconazole only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183550 | Mirtazapine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183550 | Mirtazapine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183551 | Morphine and naltrexone only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183551 | Morphine and naltrexone only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183552 | Morphine and naltrexone only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183552 | Morphine and naltrexone only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183553 | 4-hydroxybutyric acid only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183553 | 4-hydroxybutyric acid only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183554 | 4-hydroxybutyric acid only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183554 | 4-hydroxybutyric acid only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183555 | Abatacept only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183555 | Abatacept only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183556 | AbobotulinumtoxinA only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183556 | AbobotulinumtoxinA only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183557 | Bovine hyaluronidase only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183557 | Bovine hyaluronidase only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183558 | Bovine hyaluronidase only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183558 | Bovine hyaluronidase only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183559 | Brexanolone only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183559 | Brexanolone only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183560 | Brexanolone only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183560 | Brexanolone only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183561 | Brimonidine and timolol only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183561 | Brimonidine and timolol only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183562 | Bromfenac only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183562 | Bromfenac only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183563 | Bromazine and codeine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183563 | Bromazine and codeine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183563 | Bromazine and codeine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183564 | Brompheniramine and codeine and phenylpropanolamine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183564 | Brompheniramine and codeine and phenylpropanolamine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183565 | Brompheniramine and codeine and phenylpropanolamine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183565 | Brompheniramine and codeine and phenylpropanolamine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183566 | Brompheniramine and dextromethorphan and phenylpropanolamine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183566 | Brompheniramine and dextromethorphan and phenylpropanolamine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183567 | Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183567 | Brompheniramine and dextromethorphan and phenylpropanolamine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183568 | Brompheniramine and dextromethorphan and pseudoephedrine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183568 | Brompheniramine and dextromethorphan and pseudoephedrine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183569 | Brompheniramine and dextromethorphan and pseudoephedrine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183569 | Brompheniramine and dextromethorphan and pseudoephedrine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218357 | Micatin Foot Powder Deodorant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183570 | Fluorometholone and sulfacetamide only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183570 | Fluorometholone and sulfacetamide only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183571 | Fluorometholone and sulfacetamide only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183571 | Fluorometholone and sulfacetamide only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183572 | Fluorometholone and tobramycin only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183572 | Fluorometholone and tobramycin only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183573 | Folinic acid only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183573 | Folinic acid only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183573 | Folinic acid only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183575 | Follitropin alfa only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183575 | Follitropin alfa only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183576 | Mucin and xylitol only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183576 | Mucin and xylitol only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183578 | Mycophenolic acid only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183578 | Mycophenolic acid only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183579 | Naphazoline and pheniramine only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183579 | Naphazoline and pheniramine only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183580 | Naphazoline and polyvinyl alcohol and zinc sulfate only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183580 | Naphazoline and polyvinyl alcohol and zinc sulfate only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183581 | AbobotulinumtoxinA only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183581 | AbobotulinumtoxinA only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183582 | Brompheniramine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183582 | Brompheniramine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183583 | Adrenaline and bupivacaine only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183583 | Adrenaline and bupivacaine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183583 | Adrenaline and bupivacaine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183584 | Fosfomycin only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183584 | Fosfomycin only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183585 | Frangula and Sterculia gum only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183585 | Frangula and Sterculia gum only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183586 | Gadoteric acid only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183586 | Gadoteric acid only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183587 | Gadoteric acid only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183587 | Gadoteric acid only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183588 | Gelatin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183588 | Gelatin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183589 | Indacaterol only product in pulmonary dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183589 | Indacaterol only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183590 | Indigo carmine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183590 | Indigo carmine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183590 | Indigo carmine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183591 | Indigo carmine only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183591 | Indigo carmine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183591 | Indigo carmine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183592 | Neomycin and prednisolone only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183592 | Neomycin and prednisolone only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183593 | Neomycin and prednisolone only product in otic dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183593 | Neomycin and prednisolone only product in otic dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183594 | Nepafenac only product in ocular dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183594 | Nepafenac only product in ocular dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183595 | Nicotinic acid and simvastatin only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183595 | Nicotinic acid and simvastatin only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183595 | Nicotinic acid and simvastatin only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183596 | Nicotine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183596 | Nicotine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183597 | Amlexanox only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183597 | Amlexanox only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183598 | Cabazitaxel only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183598 | Cabazitaxel only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183599 | Calamine and dimeticone and zinc oxide only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183599 | Calamine and dimeticone and zinc oxide only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183599 | Calamine and dimeticone and zinc oxide only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183600 | Calamine and dimeticone and zinc oxide only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183600 | Calamine and dimeticone and zinc oxide only product in cutaneous dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183600 | Calamine and dimeticone and zinc oxide only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183601 | Calaspargase pegol only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183601 | Calaspargase pegol only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183602 | Calaspargase pegol only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183602 | Calaspargase pegol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183603 | Calcium carbonate and famotidine and magnesium hydroxide only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183603 | Calcium carbonate and famotidine and magnesium hydroxide only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183604 | Dalbavancin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183604 | Dalbavancin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183605 | Fampridine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183605 | Fampridine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183605 | Fampridine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183606 | Methylrosanilinium chloride only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183606 | Methylrosanilinium chloride only product in cutaneous dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183606 | Methylrosanilinium chloride only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183607 | Gilteritinib only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183607 | Gilteritinib only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183608 | Gilteritinib only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183608 | Gilteritinib only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183609 | Glasdegib only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183609 | Glasdegib only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183610 | Glasdegib only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183610 | Glasdegib only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183611 | Inotersen only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183611 | Inotersen only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183612 | Inotersen only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183612 | Inotersen only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183613 | Iodinated (125-I) human serum albumin only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183613 | Iodinated (125-I) human serum albumin only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183614 | Iodinated (125-I) human serum albumin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183614 | Iodinated (125-I) human serum albumin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183615 | Iodohippurate (123-I) sodium only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183615 | Iodohippurate (123-I) sodium only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183616 | Iodohippurate (123-I) sodium only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183616 | Iodohippurate (123-I) sodium only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183617 | Iothalamic acid only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183617 | Iothalamic acid only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183618 | Iotroxic acid only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183618 | Iotroxic acid only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183619 | Iotroxic acid only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183619 | Iotroxic acid only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218362 | Micon-80 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183620 | Norcholestenol iodomethyl (131-I) only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183620 | Norcholestenol iodomethyl (131-I) only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183621 | Norcholestenol iodomethyl (131-I) only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183621 | Norcholestenol iodomethyl (131-I) only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183622 | Noxytiolin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183622 | Noxytiolin only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183622 | Noxytiolin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183623 | Amlodipine and hydrochlorothiazide and olmesartan only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183623 | Amlodipine and hydrochlorothiazide and olmesartan only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183624 | Amlodipine and hydrochlorothiazide and valsartan only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183624 | Amlodipine and hydrochlorothiazide and valsartan only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183625 | Amlodipine only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183625 | Amlodipine only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183626 | Ammonium lactate and salicylic acid only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183626 | Ammonium lactate and salicylic acid only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183627 | Ammonium lactate and salicylic acid only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183627 | Ammonium lactate and salicylic acid only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183628 | Product containing only sodium ferric gluconate complex (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183628 | Product containing only sodium ferric gluconate complex (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183629 | Product containing only sodium ferric gluconate complex in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183629 | Product containing only sodium ferric gluconate complex in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183630 | Product containing only sodium iodide (131-I) (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183630 | Product containing only sodium iodide (131-I) (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183631 | Product containing only sodium iodide (131-I) in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183631 | Product containing only sodium iodide (131-I) in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183632 | Product containing only sodium iodide (131-I) in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183632 | Product containing only sodium iodide (131-I) in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183633 | Product containing only sodium thiosalicylate (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183633 | Product containing only sodium thiosalicylate (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183634 | Product containing only sodium thiosalicylate in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183634 | Product containing only sodium thiosalicylate in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183635 | Product containing only solriamfetol (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183635 | Product containing only solriamfetol (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183636 | Product containing only solriamfetol in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183636 | Product containing only solriamfetol in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183637 | Product containing only Sterculia gum in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183637 | Product containing only Sterculia gum in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183638 | Product containing only streptozocin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183638 | Product containing only streptozocin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183639 | Product containing only sucrose in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183639 | Product containing only sucrose in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 218364 | Micrainin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183640 | Product containing only sufentanil in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183640 | Product containing only sufentanil in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183642 | Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183642 | Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183643 | Product containing only tagraxofusp (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183643 | Product containing only tagraxofusp (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183644 | Product containing only tagraxofusp in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183644 | Product containing only tagraxofusp in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183645 | Product containing only tedizolid in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183645 | Product containing only tedizolid in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183646 | Product containing only telavancin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183646 | Product containing only telavancin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183647 | Product containing only temoporfin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183647 | Product containing only temoporfin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183648 | Product containing only temozolomide in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183648 | Product containing only temozolomide in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183649 | Product containing only tenecteplase in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183649 | Product containing only tenecteplase in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 218365 | Micro-K | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183650 | Product containing only teniposide in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183650 | Product containing only teniposide in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183652 | Product containing only thioglycolic acid (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183652 | Product containing only thioglycolic acid (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183653 | Product containing only ticarcillin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183653 | Product containing only ticarcillin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183654 | Product containing only tramadol in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183654 | Product containing only tramadol in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183655 | Product containing only treprostinil in pulmonary dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183655 | Product containing only treprostinil in pulmonary dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183656 | Product containing only tuberculin purified protein derivative in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183656 | Product containing only tuberculin purified protein derivative in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183657 | Product containing only urofollitropin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183657 | Product containing only urofollitropin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183658 | Product containing only urokinase in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183658 | Product containing only urokinase in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183659 | Product containing only Vaccinia human immune globulin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183659 | Product containing only Vaccinia human immune globulin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183660 | Product containing only vardenafil in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183660 | Product containing only vardenafil in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183661 | Product containing only Varicella-zoster virus antibody in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183661 | Product containing only Varicella-zoster virus antibody in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183662 | Product containing only vedolizumab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183662 | Product containing only vedolizumab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183663 | Product containing only velaglucerase alfa in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183663 | Product containing only velaglucerase alfa in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183664 | Product containing only von Willebrand factor in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183664 | Product containing only von Willebrand factor in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183665 | Product containing only zoledronic acid in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183665 | Product containing only zoledronic acid in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183666 | Product containing only zolmitriptan in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183666 | Product containing only zolmitriptan in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183667 | Product containing only zolpidem in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183667 | Product containing only zolpidem in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183668 | hydrocodone tannate 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2183668 | hydrocodone tannate 1 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2183669 | chlorpheniramine 4 MG / HYDROcodone bitartrate 5 MG in 5 mL Extended Release Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2183669 | chlorpheniramine 4 MG / HYDROcodone bitartrate 5 MG in 5 mL Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183669 | chlorpheniramine 4 MG / HYDROcodone bitartrate 5 MG in 5 mL Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2183669 | chlorpheniramine 4 MG / HYDROcodone bitartrate 5 MG in 5 mL Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2183669 | chlorpheniramine 4 MG / HYDROcodone bitartrate 5 MG in 5 mL Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 218367 | Micro-K LS | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183670 | chlorpheniramine tannate 0.8 MG/ML / hydrocodone tannate 1 MG/ML [HyTan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2183670 | chlorpheniramine tannate 0.8 MG/ML / hydrocodone tannate 1 MG/ML [HyTan] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2183671 | chlorpheniramine tannate 0.8 MG/ML / hydrocodone tannate 1 MG/ML Extended Release Suspension [HyTan] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2183671 | chlorpheniramine tannate 0.8 MG/ML / hydrocodone tannate 1 MG/ML Extended Release Suspension [HyTan] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2183671 | chlorpheniramine tannate 0.8 MG/ML / hydrocodone tannate 1 MG/ML Extended Release Suspension [HyTan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183671 | chlorpheniramine tannate 0.8 MG/ML / hydrocodone tannate 1 MG/ML Extended Release Suspension [HyTan] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2183672 | chlorpheniramine tannate 4 MG / phenylephrine tannate 20 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2183672 | chlorpheniramine tannate 4 MG / phenylephrine tannate 20 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2183672 | chlorpheniramine tannate 4 MG / phenylephrine tannate 20 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183675 | chlorpheniramine tannate 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2183676 | chlorpheniramine tannate 1 MG/mL / pseudoephedrine tannate 15 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2183676 | chlorpheniramine tannate 1 MG/mL / pseudoephedrine tannate 15 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2183680 | chlorpheniramine maleate 1.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2183681 | chlorpheniramine maleate 1.6 MG/ML / phenylephrine hydrochloride 2 MG/ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2183684 | chlorpheniramine tannate 1.6 MG/mL / phenylephrine tannate 2 MG/mL Extended Release Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2183684 | chlorpheniramine tannate 1.6 MG/mL / phenylephrine tannate 2 MG/mL Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2183687 | chlorpheniramine tannate 1.6 MG/mL Extended Release Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2183687 | chlorpheniramine tannate 1.6 MG/mL Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2183688 | chlorpheniramine tannate 1.6 MG/ML [P-Tann] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2183689 | chlorpheniramine tannate 1.6 MG/ML Extended Release Suspension [P-Tann] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 218369 | Microzide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183690 | chlorpheniramine tannate 1.6 MG/ML [ChlorTan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2183691 | chlorpheniramine tannate 1.6 MG/ML Extended Release Suspension [ChlorTan] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2183692 | Alprostadil 10 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183692 | Alprostadil 10 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183694 | Alprostadil 20 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183694 | Alprostadil 20 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183695 | Antidiuretic hormone 20 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183695 | Antidiuretic hormone 20 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183696 | Bacitracin A 50000 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183696 | Bacitracin A 50000 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183697 | chlorpheniramine maleate 2 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2183697 | chlorpheniramine maleate 2 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2183698 | chlorpheniramine maleate 2 MG [Chlo-Amine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2183699 | chlorpheniramine maleate 2 MG Chewable Tablet [Chlo-Amine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183699 | chlorpheniramine maleate 2 MG Chewable Tablet [Chlo-Amine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 21837 | cupric oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 218370 | Midchlor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183700 | Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183700 | Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2183700 | Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183700 | Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183701 | chlorpheniramine maleate 8 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2183701 | chlorpheniramine maleate 8 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2183702 | chlorpheniramine maleate 8 MG [Prohist-8] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2183703 | chlorpheniramine maleate 8 MG Extended Release Oral Capsule [Prohist-8] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2183704 | chlorpheniramine maleate 8 MG [Chlor-Phen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2183705 | chlorpheniramine maleate 8 MG Extended Release Oral Capsule [Chlor-Phen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183705 | chlorpheniramine maleate 8 MG Extended Release Oral Capsule [Chlor-Phen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2183710 | Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183710 | Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183711 | Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183711 | Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183714 | Budesonide 250 microgram/mL solution for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183714 | Budesonide 250 microgram/mL solution for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183715 | Budesonide 500 microgram/mL solution for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183715 | Budesonide 500 microgram/mL solution for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183717 | Colistimethate 40 mg/mL solution for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183717 | Colistimethate 40 mg/mL solution for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183719 | Sodium cromoglicate 5 mg/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183719 | Sodium cromoglicate 5 mg/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183719 | Sodium cromoglicate 5 mg/actuation powder for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183721 | Fenoterol 500 microgram and ipratropium 1.25 mg/actuation solution for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183721 | Fenoterol 500 microgram and ipratropium 1.25 mg/actuation solution for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183722 | Fluticasone propionate 1 mg/mL solution for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183722 | Fluticasone propionate 1 mg/mL solution for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183723 | Fluticasone propionate 250 microgram/mL solution for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183723 | Fluticasone propionate 250 microgram/mL solution for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183724 | Ipratropium bromide 250 microgram/mL solution for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183724 | Ipratropium bromide 250 microgram/mL solution for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183725 | Ipratropium bromide 40 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183725 | Ipratropium bromide 40 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183726 | Pentamidine isetionate 60 mg/mL solution for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183726 | Pentamidine isetionate 60 mg/mL solution for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183726 | Pentamidine isetionate 60 mg/mL solution for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183727 | Product containing precisely terbutaline sulfate 10 milligram/1 milliliter conventional release solution for inhalation (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183727 | Product containing precisely terbutaline sulfate 10 milligram/1 milliliter conventional release solution for inhalation (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183728 | Product containing precisely terbutaline sulfate 2.5 milligram/1 milliliter conventional release solution for inhalation (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183728 | Product containing precisely terbutaline sulfate 2.5 milligram/1 milliliter conventional release solution for inhalation (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183729 | Product containing precisely terbutaline sulfate 200 microgram/1 milliliter conventional release solution for inhalation (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183729 | Product containing precisely terbutaline sulfate 200 microgram/1 milliliter conventional release solution for inhalation (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 218377 | Migergot | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218378 | Migquin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218381 | Migrapap | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218382 | Migratine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218383 | Migrazone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218384 | Migrex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218386 | Milkinol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218387 | Milontin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218388 | Mineral ice | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218389 | Minidyne | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183890 | Bovine isophane insulin 100 unit/mL suspension for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183890 | Bovine isophane insulin 100 unit/mL suspension for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183891 | Chlorphenamine maleate 8 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183891 | Chlorphenamine maleate 8 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183891 | Chlorphenamine maleate 8 mg oral tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2183891 | Chlorphenamine maleate 8 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183892 | chlorpheniramine tannate 8 MG [Ed Chlor Tan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2183893 | chlorpheniramine tannate 8 MG Oral Tablet [Ed Chlor Tan] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2183893 | chlorpheniramine tannate 8 MG Oral Tablet [Ed Chlor Tan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183894 | Equine antithymocyte immunoglobulin 20 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183894 | Equine antithymocyte immunoglobulin 20 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183896 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2183897 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG [Tannic-12 S] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2183898 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG Oral Tablet [Tannic-12 S] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2183898 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG Oral Tablet [Tannic-12 S] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183899 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG [Trionate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2183900 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG Oral Tablet [Trionate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2183901 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG [Tussi-12] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2183902 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG Oral Tablet [Tussi-12] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2183902 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG Oral Tablet [Tussi-12] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183903 | Human anti-D immunoglobulin 1250 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183903 | Human anti-D immunoglobulin 1250 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183904 | Human chorionic gonadotropin 10000 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183904 | Human chorionic gonadotropin 10000 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183905 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG [Tussizone-12 RF] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2183906 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG Oral Tablet [Tussizone-12 RF] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2183907 | dexchlorpheniramine maleate 2 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2183907 | dexchlorpheniramine maleate 2 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2183907 | dexchlorpheniramine maleate 2 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2183908 | dexchlorpheniramine maleate 0.4 MG/ML [Polaramine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2183909 | Polaramine 2 MG per 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2183909 | Polaramine 2 MG per 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2183909 | Polaramine 2 MG per 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 218391 | Minitabs | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2183910 | Product containing precisely warfarin sodium 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2183910 | Product containing precisely warfarin sodium 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2183911 | dexchlorpheniramine maleate 0.4 MG/ML [Ryclora] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2183912 | RyClora 2 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2183912 | RyClora 2 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2183912 | RyClora 2 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2183912 | RyClora 2 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 218392 | Minizide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218393 | Minotal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218394 | Mintox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218395 | Mintox Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2184 | Cefoperazone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2184 | Cefoperazone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184 | Cefoperazone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184 | Cefoperazone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184 | Cefoperazone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218401 | Miradon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218402 | Mirapex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218408 | Mitrazol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2184083 | Hydralazine hydrochloride 20 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184083 | Hydralazine hydrochloride 20 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184084 | Interferon beta-1a 30 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184084 | Interferon beta-1a 30 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184086 | Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184086 | Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184086 | Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184088 | dexchlorpheniramine tannate 0.6 MG/mL / pseudoephedrine tannate 10 MG/mL Extended Release Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2184088 | dexchlorpheniramine tannate 0.6 MG/mL / pseudoephedrine tannate 10 MG/mL Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 218409 | Mitride | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2184091 | Gentamicin (as gentamicin sulfate) 10 mg/mL cutaneous cream | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184091 | Gentamicin (as gentamicin sulfate) 10 mg/mL cutaneous cream | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184093 | Indoramin (as indoramin hydrochloride) 20 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184093 | Indoramin (as indoramin hydrochloride) 20 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184094 | Indoramin (as indoramin hydrochloride) 25 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184094 | Indoramin (as indoramin hydrochloride) 25 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184095 | Iodine (as povidone iodine) 100 mg/g vaginal gel | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184095 | Iodine (as povidone iodine) 100 mg/g vaginal gel | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184096 | Iodine (as povidone iodine) 200 mg vaginal tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184096 | Iodine (as povidone iodine) 200 mg vaginal tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184099 | Cefmetazole (as cefmetazole sodium) 1 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184099 | Cefmetazole (as cefmetazole sodium) 1 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218410 | Mobidin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2184100 | Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184100 | Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184101 | Cefoperazone (as cefoperazone sodium) 1 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184101 | Cefoperazone (as cefoperazone sodium) 1 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184102 | Cefoperazone (as cefoperazone sodium) 10 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184102 | Cefoperazone (as cefoperazone sodium) 10 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184103 | Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184103 | Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184106 | Ceftazidime anhydrous (as ceftazidime) 40 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184106 | Ceftazidime anhydrous (as ceftazidime) 40 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184107 | Ceftizoxime (as ceftizoxime sodium) 10 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184107 | Ceftizoxime (as ceftizoxime sodium) 10 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184108 | dexchlorpheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2184108 | dexchlorpheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 218411 | Mobigesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2184111 | Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184111 | Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184112 | Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184112 | Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184112 | Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 20 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184114 | Ferric ion (as sodium ferric gluconate complex) 12.5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184114 | Ferric ion (as sodium ferric gluconate complex) 12.5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184116 | amlodipine benzoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2184116 | amlodipine benzoate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2184116 | amlodipine benzoate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2184116 | amlodipine benzoate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2184117 | amLODIPine 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2184117 | amLODIPine 1 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2184118 | amLODIPine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2184118 | amLODIPine Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2184119 | amLODIPine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2184119 | amLODIPine Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2184120 | amLODIPine 1 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2184120 | amLODIPine 1 MG/mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2184120 | amLODIPine 1 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2184120 | amLODIPine 1 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2184120 | amLODIPine 1 MG/mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2184121 | Katerzia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2184122 | amLODIPine 1 MG/ML [Katerzia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2184122 | amLODIPine 1 MG/ML [Katerzia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2184123 | amLODIPine Oral Suspension [Katerzia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2184123 | amLODIPine Oral Suspension [Katerzia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2184124 | Katerzia Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2184125 | Katerzia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2184126 | Katerzia 1 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2184126 | Katerzia 1 MG/mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2184126 | Katerzia 1 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2184126 | Katerzia 1 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2184127 | dexchlorpheniramine maleate 6 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184128 | dexchlorpheniramine maleate 6 MG [Polaramine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2184129 | dexchlorpheniramine maleate 6 MG Extended Release Oral Tablet [Polaramine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2184129 | dexchlorpheniramine maleate 6 MG Extended Release Oral Tablet [Polaramine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184130 | Dexchlorpheniramine maleate 6 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184130 | Dexchlorpheniramine maleate 6 mg oral tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184130 | Dexchlorpheniramine maleate 6 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184131 | acetaminophen 325 MG / chlorpheniramine maleate 8 MG / phenylephrine HCl 40 MG / phenyltoloxamine citrate 50 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184131 | acetaminophen 325 MG / chlorpheniramine maleate 8 MG / phenylephrine HCl 40 MG / phenyltoloxamine citrate 50 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184131 | acetaminophen 325 MG / chlorpheniramine maleate 8 MG / phenylephrine HCl 40 MG / phenyltoloxamine citrate 50 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184131 | acetaminophen 325 MG / chlorpheniramine maleate 8 MG / phenylephrine HCl 40 MG / phenyltoloxamine citrate 50 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184131 | acetaminophen 325 MG / chlorpheniramine maleate 8 MG / phenylephrine HCl 40 MG / phenyltoloxamine citrate 50 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2184132 | APAP 325 MG / Chlorpheniramine Maleate 8 MG / Phenylephrine Hydrochloride 40 MG / Phenyltoloxamine citrate 50 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184132 | APAP 325 MG / Chlorpheniramine Maleate 8 MG / Phenylephrine Hydrochloride 40 MG / Phenyltoloxamine citrate 50 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184133 | 12 HR chlorpheniramine maleate 12 MG / methscopolamine nitrate 1.25 MG / phenylephrine hydrochloride 40 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184134 | chlorpheniramine maleate 12 MG / methscopolamine nitrate 1.25 MG / phenylephrine hydrochloride 40 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184135 | Imipenem monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2184135 | Imipenem monohydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184135 | Imipenem monohydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184136 | relebactam monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2184136 | relebactam monohydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184136 | relebactam monohydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184137 | Relebactam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2184137 | Relebactam | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2184137 | Relebactam | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2184138 | relebactam 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2184139 | Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2184139 | Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2184139 | Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 218414 | Modane Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2184140 | cilastatin / imipenem / relebactam Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2184141 | Cilastatin- and imipenem- and relebactam-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2184141 | Cilastatin- and imipenem- and relebactam-containing product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2184141 | Cilastatin- and imipenem- and relebactam-containing product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2184142 | cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2184142 | cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2184143 | Recarbrio | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2184144 | cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG [Recarbrio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2184145 | cilastatin / imipenem / relebactam Injection [Recarbrio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2184146 | Recarbrio Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2184147 | Recarbrio 500 MG / 500 MG / 250 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2184147 | Recarbrio 500 MG / 500 MG / 250 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2184147 | Recarbrio 500 MG / 500 MG / 250 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2184148 | methscopolamine nitrate 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2184149 | chlorpheniramine maleate 12 MG / methscopolamine nitrate 2 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184149 | chlorpheniramine maleate 12 MG / methscopolamine nitrate 2 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184149 | chlorpheniramine maleate 12 MG / methscopolamine nitrate 2 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 218415 | Modane Soft | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2184150 | chlorpheniramine maleate 12 MG / methscopolamine nitrate 2 MG / phenylephrine hydrochloride 40 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184152 | ibuprofen 200 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2184152 | ibuprofen 200 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2184153 | chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 20 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184158 | phenylephrine HCl 20 MG / chlorpheniramine maleate 4 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184158 | phenylephrine HCl 20 MG / chlorpheniramine maleate 4 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184158 | phenylephrine HCl 20 MG / chlorpheniramine maleate 4 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2184164 | chlorpheniramine maleate 8 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184164 | chlorpheniramine maleate 8 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2184165 | chlorpheniramine maleate 8 MG / phenylephrine HCl 20 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2184165 | chlorpheniramine maleate 8 MG / phenylephrine HCl 20 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184166 | chlorpheniramine maleate 8 MG / phenylephrine HCl 40 MG / scopolamine 2.5 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2184166 | chlorpheniramine maleate 8 MG / phenylephrine HCl 40 MG / scopolamine 2.5 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184167 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG / phenylephrine tannate 10 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184167 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG / phenylephrine tannate 10 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2184168 | carbetapentane tannate 60 MG / chlorpheniramine tannate 5 MG / phenylephrine tannate 10 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184169 | dexchlorpheniramine maleate 3.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2184170 | methscopolamine nitrate 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2184171 | dexchlorpheniramine maleate 3.5 MG / methscopolamine nitrate 1 MG / pseudoephedrine HCl 45 MG 12 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184171 | dexchlorpheniramine maleate 3.5 MG / methscopolamine nitrate 1 MG / pseudoephedrine HCl 45 MG 12 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184172 | dexchlorpheniramine maleate 3.5 MG / methscopolamine nitrate 1 MG / pseudoephedrine HCl 45 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184172 | dexchlorpheniramine maleate 3.5 MG / methscopolamine nitrate 1 MG / pseudoephedrine HCl 45 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184174 | phenylephrine hydrochloride 18.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2184175 | dexchlorpheniramine maleate 3.5 MG / phenylephrine HCl 18.5 MG 12 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184175 | dexchlorpheniramine maleate 3.5 MG / phenylephrine HCl 18.5 MG 12 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184176 | dexchlorpheniramine maleate 3.5 MG / phenylephrine hydrochloride 18.5 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2184176 | dexchlorpheniramine maleate 3.5 MG / phenylephrine hydrochloride 18.5 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184177 | chlorpheniramine maleate 6 MG / pseudoephedrine HCl 120 MG / methscopolamine nitrate 2.5 MG 24 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2184177 | chlorpheniramine maleate 6 MG / pseudoephedrine HCl 120 MG / methscopolamine nitrate 2.5 MG 24 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 218418 | Moisturel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2184182 | acebutolol 200 MG [Sectral] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2184185 | acebutolol 400 MG [Sectral] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2184188 | Fluoride ion (as sodium fluoride) 2.21 mg oromucosal lozenge | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184188 | Fluoride ion (as sodium fluoride) 2.21 mg oromucosal lozenge | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184191 | Loprazolam (as loprazolam mesilate) 1 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2184191 | Loprazolam (as loprazolam mesilate) 1 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184191 | Loprazolam (as loprazolam mesilate) 1 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184192 | Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184192 | Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 21842 | Copper oxide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 21842 | Copper oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 21842 | Copper oxide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 21842 | Copper oxide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 21842 | Copper oxide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 21842 | Copper oxide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 218420 | Mol-Iron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218421 | Mollifene | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218423 | Momentum tradename | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218425 | Monarc-M | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218428 | Monistat 7 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218429 | Mono-Gesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218431 | Monocal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218432 | Monodox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218433 | Monojel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218439 | Mosco Corn & Callus Remover | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2184390 | Primaquine (as primaquine phosphate) 7.5 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184390 | Primaquine (as primaquine phosphate) 7.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184391 | Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184391 | Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184393 | hypochlorite Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2184394 | sodium hypochlorite 0.125 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2184394 | sodium hypochlorite 0.125 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2184394 | sodium hypochlorite 0.125 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2184396 | Salbutamol (as salbutamol sulfate) 2.5 mg/actuation solution for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184396 | Salbutamol (as salbutamol sulfate) 2.5 mg/actuation solution for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184396 | Salbutamol (as salbutamol sulfate) 2.5 mg/actuation solution for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 218440 | Mosco Nail A Cain | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218441 | Mosco-Cain | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218444 | Motion-Aid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218445 | Motofen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2184490 | Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184490 | Product containing precisely streptokinase 1.5 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184491 | Product containing precisely streptokinase 250000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184491 | Product containing precisely streptokinase 250000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184492 | Product containing precisely streptokinase 750000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184492 | Product containing precisely streptokinase 750000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 218453 | Mucobid-L.A. | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218454 | Mucomyst-10 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218455 | Mucomyst-20 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218456 | Mudrane | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218457 | Mudrane GG | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218458 | Mudrane GG-2 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218460 | MulTE-PAK-5 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218472 | Multihistamine-D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2184790 | Caffeinated coffee | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2184790 | Caffeinated coffee | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218482 | Multitrace-4 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218486 | Multitrace-5 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218491 | Murine Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218492 | Muro 128 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218493 | Murocel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218494 | Murocoll 2 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218498 | Mycasone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2184990 | Product containing precisely sumatriptan succinate 12 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2184990 | Product containing precisely sumatriptan succinate 12 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185 | Cefotan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218501 | Mycelex-7 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218502 | Mycelex-G | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218503 | Myci | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218504 | Myciguent | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218505 | Mycinette Sore Throat Spray | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218506 | Mycitracin Triple Antibiotic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218511 | Mycomar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218512 | Mydfrin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218513 | Mydral | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218515 | Myfedrine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218517 | Mygel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218519 | Mygracet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218520 | Mylagel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218522 | Mylagen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218527 | Mylaval | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218528 | Mylicon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2185290 | Lutropin alfa 75 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185290 | Lutropin alfa 75 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2185291 | Metronidazole 500 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185291 | Metronidazole 500 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2185292 | Noxytiolin 2.5 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185292 | Noxytiolin 2.5 g powder for solution for injection vial | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2185292 | Noxytiolin 2.5 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2185295 | Interferon beta-1a 24 million unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185295 | Interferon beta-1a 24 million unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2185296 | Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185296 | Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2185297 | Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185297 | Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2185298 | Glucose 100 mg/mL and sodium chloride 1.8 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185298 | Glucose 100 mg/mL and sodium chloride 1.8 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2185299 | Potassium chloride 100 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185299 | Potassium chloride 100 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2185300 | alpha-D-galactosidase enzyme 400 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2185301 | alpha-d-galactosidase enzyme 400 UNT Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2185301 | alpha-d-galactosidase enzyme 400 UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2185302 | alpha-D-galactosidase enzyme 400 UNT [Beano] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2185303 | Beano 400 UNT Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2185303 | Beano 400 UNT Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2185303 | Beano 400 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2185304 | Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185304 | Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2185309 | vitamin B 12 500 MCG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2185309 | vitamin B 12 500 MCG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2185309 | vitamin B 12 500 MCG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 218540 | Myphetane DC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218541 | Myphetane DX | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218544 | Mytab Gas | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218547 | Mytrex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218548 | Mytussin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218549 | Mytussin AC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218550 | Mytussin DAC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218554 | N'ICE | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218556 | N Ice with Vitamin C | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218557 | N.T.A. | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218560 | NP-27 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218562 | NTZ Long Acting Nasal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218563 | Nafazair | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218564 | Naftin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2185690 | Drospirenone- and ethinylestradiol- and levomefolic acid-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185690 | Drospirenone- and ethinylestradiol- and levomefolic acid-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2185690 | Drospirenone- and ethinylestradiol- and levomefolic acid-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218574 | Naldecon-EX Senior | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2185790 | 17-hydroxystearic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2185791 | sorbeth-12 hexaoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 218580 | Nalex Expectorant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218583 | Nalex DH | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218589 | Nallpen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218598 | Naphcon A | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218599 | Naprelan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2185991 | GHB receptor agonist-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185991 | GHB receptor agonist-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2185991 | GHB receptor agonist-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2185993 | GLP-2 receptor agonist-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2185993 | GLP-2 receptor agonist-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185993 | GLP-2 receptor agonist-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2185995 | Ghrelin receptor agonist-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2185995 | Ghrelin receptor agonist-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2185995 | Ghrelin receptor agonist-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2185996 | dimethicone 0.03 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2185997 | camphor / dimethicone / lidocaine / menthol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2185998 | camphor / dimethicone / lidocaine / menthol Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2185999 | camphor / dimethicone / lidocaine / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2186 | Cefotaxime | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2186 | Cefotaxime | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2186 | Cefotaxime | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2186 | Cefotaxime | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2186 | Cefotaxime | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2186001 | camphor 3 % / dimethicone 3 % / lidocaine 4 % / menthol 1 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2186001 | camphor 3 % / dimethicone 3 % / lidocaine 4 % / menthol 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2186001 | camphor 3 % / dimethicone 3 % / lidocaine 4 % / menthol 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2186002 | Serotonin 5-hydroxytryptamine-4 receptor agonist-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2186002 | Serotonin 5-hydroxytryptamine-4 receptor agonist-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2186002 | Serotonin 5-hydroxytryptamine-4 receptor agonist-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 218606 | Nasahist B | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2186090 | chlorhexidine Medicated Liquid Soap [Bactoshield] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2186091 | Bactoshield Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2186092 | Bactoshield 4 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2186092 | Bactoshield 4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2186092 | Bactoshield 4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2186092 | Bactoshield 4 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2186093 | Chlorinated phenol disinfectant | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2186093 | Chlorinated phenol disinfectant | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218613 | Nasal Moist | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2186190 | Esomeprazole magnesium trihydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2186190 | Esomeprazole magnesium trihydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218620 | Nasalide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218621 | Nasarel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218623 | Nasatuss | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218635 | Natural Thyroid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218638 | Natures Remedy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218644 | Navogan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218645 | Nebcin Pediatric | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218646 | NebuPent | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218650 | Neggram | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218656 | Neo-Calglucon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218657 | Neo-Cortef | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218658 | Neo-Decadron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218661 | Neo-Dex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218662 | Neo-Dexair | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218667 | Neo-Synephrine 12 Hour | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218670 | Neo-Tab | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218672 | Neocin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218673 | Neocin PG | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218678 | Neopap Supprettes | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218679 | Neoptic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2186791 | Cytochrome P450 inhibitor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2186791 | Cytochrome P450 inhibitor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2186795 | Phosphoribosylglycinamide formyltransferase inhibitor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2186795 | Phosphoribosylglycinamide formyltransferase inhibitor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2186798 | Substance with transthyretin synthesis inhibitor mechanism of action (substance) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2186798 | Substance with transthyretin synthesis inhibitor mechanism of action (substance) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2186800 | 4-hydroxyphenylpyruvate dioxygenase inhibitor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2186800 | 4-hydroxyphenylpyruvate dioxygenase inhibitor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2186801 | Alkaline phosphatase inhibitor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2186801 | Alkaline phosphatase inhibitor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218684 | Neothylline | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218686 | Neotricin HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218688 | Nephramine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218689 | Nephro Calci | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218691 | Nephro-Fer | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218692 | Nephro-Fer RX | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218696 | Nephron brand of racepinephrine hydrochloride | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218698 | Nephrox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218699 | Neptazane | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2187 | Cefotetan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2187 | Cefotetan | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2187 | Cefotetan | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2187 | Cefotetan | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2187 | Cefotetan | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2187 | Cefotetan | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 218700 | Nervine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218701 | Nervocaine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218706 | Neuroforte-R | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218708 | Neut brand of sodium bicarbonate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2187090 | Bosentan hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2187090 | Bosentan hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218710 | Neutra-Phos-K | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218728 | Niacor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218729 | Niacor B3 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218731 | Nicobid Tempules | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218733 | Nicotinex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218734 | Nicotrol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2187392 | Olanzapine embonate monohydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2187392 | Olanzapine embonate monohydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218741 | Nilandron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218744 | Nitrek | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218747 | Nitro-Par | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218749 | Nitrocot | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218750 | Nitrogard | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218751 | Nitroglyn E-R | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218753 | Nitropress | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218754 | Nitroquick | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218756 | Nix Cream Rinse | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218759 | Nogenic HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 21877 | cyamemazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 218772 | Norco | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218775 | Norethin 1/50 M | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218776 | Norgesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218778 | Noritate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 21878 | Cyanase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 21878 | Cyanase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21878 | Cyanase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 21878 | Cyanase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 218783 | Norwich Aspirin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218784 | Nostrilla | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218785 | Notuss | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218786 | Novacet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218787 | Novadyne DH | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218788 | Novadyne Expectorant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218792 | Novarel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218794 | Nu-Iron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218795 | Nu-Iron 150 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218798 | Nu-Med | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2188 | Cefotiam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2188 | Cefotiam | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2188 | Cefotiam | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2188 | Cefotiam | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2188 | Cefotiam | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218803 | Nucochem | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218806 | Nucodine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218807 | Nucodine Expectorant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218809 | Nucofed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2188090 | polyglyceryl-2 myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 218814 | Nupercainal HC 1% | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218815 | Nuprin Backache | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218816 | Nuquin HP | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218820 | Nutraplus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218830 | Nystop | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218837 | Obenix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218838 | Obephen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218839 | Obezine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218841 | Oby-Cap | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218842 | Oby-Trim | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218843 | Ocean brand of sodium chloride | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218844 | Octycine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218845 | Octycine-100 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218846 | Octycine-250 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218847 | Ocu-Carpine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218848 | Ocu-Cort | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218850 | Ocu-tropine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218851 | Ocuclear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218853 | Ocuflox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218854 | Ocuhist | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218855 | Ocumycin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218856 | Ocupress | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218858 | Ocusulf-10 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218859 | Ocutricin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218860 | Ocuvite | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218862 | Off-Eazy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218863 | Ogen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218867 | Omni Perio-Med | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218878 | Omnipen-N | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218880 | Oncet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218883 | One Step Pinworm Treatment | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218891 | Ontak | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218892 | Ony-Clear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218893 | Opcon-A | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218896 | OptiPranolol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218897 | Opticyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2189 | Cefoxitin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2189 | Cefoxitin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2189 | Cefoxitin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2189 | Cefoxitin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2189 | Cefoxitin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2189 | Cefoxitin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 218911 | Oracit | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2189190 | Immunoglobulin A autoantibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189190 | Immunoglobulin A autoantibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2189190 | Immunoglobulin A autoantibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189191 | Free carbamazepine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189191 | Free carbamazepine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189192 | Ibuprofen sodium dihydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189192 | Ibuprofen sodium dihydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218923 | Oral B Anti-Cavity | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218929 | Orazinc | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2189292 | Desmethyldosulepin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2189292 | Desmethyldosulepin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189292 | Desmethyldosulepin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189293 | Dexamethasone sodium metasulfobenzoate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189293 | Dexamethasone sodium metasulfobenzoate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189294 | L-carnitine CoA-transferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189294 | L-carnitine CoA-transferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189296 | Medicinal product acting as pyridoxine supplement (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189296 | Medicinal product acting as pyridoxine supplement (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189297 | Medicinal product acting as pantothenic acid supplement (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189297 | Medicinal product acting as pantothenic acid supplement (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189298 | Vitamin B2 supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189298 | Vitamin B2 supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189298 | Vitamin B2 supplement agent | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2189299 | Medicinal product acting as selenium supplement (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189299 | Medicinal product acting as selenium supplement (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189300 | Chromium supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189300 | Chromium supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189301 | Manganese supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189301 | Manganese supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189302 | Ascorbic acid supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189302 | Ascorbic acid supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189303 | Cobalt supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189303 | Cobalt supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189304 | Biotin supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189304 | Biotin supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189305 | Boron supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189305 | Boron supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189306 | Medicinal product acting as phosphorus supplement (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189306 | Medicinal product acting as phosphorus supplement (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189307 | Copper supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189307 | Copper supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189308 | Vitamin B12 supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189308 | Vitamin B12 supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189308 | Vitamin B12 supplement agent | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2189309 | Fluoride supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189309 | Fluoride supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189310 | Medicinal product acting as molybdenum supplement (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189310 | Medicinal product acting as molybdenum supplement (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189311 | Nicotinic acid supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189311 | Nicotinic acid supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189311 | Nicotinic acid supplement agent | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2189312 | Iodine supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189312 | Iodine supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189313 | Iron supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189313 | Iron supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189314 | Medicinal product acting as sulfur supplement (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189314 | Medicinal product acting as sulfur supplement (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189315 | Vitamin B1 supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189315 | Vitamin B1 supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189315 | Vitamin B1 supplement agent | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2189316 | Retinol supplement agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189316 | Retinol supplement agent | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2189316 | Retinol supplement agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189323 | Silicon and/or silicon compound | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189323 | Silicon and/or silicon compound | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189324 | Oxygen and/or oxygen compound | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189324 | Oxygen and/or oxygen compound | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189325 | Rhenium and/or rhenium compound | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189325 | Rhenium and/or rhenium compound | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189326 | Samarium and/or samarium compound | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189326 | Samarium and/or samarium compound | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189327 | Metal and/or metal compound | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189327 | Metal and/or metal compound | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189328 | Product containing tin and/or tin compound (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189328 | Product containing tin and/or tin compound (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189328 | Product containing tin and/or tin compound (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189328 | Product containing tin and/or tin compound (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189329 | Product containing xenon and/or xenon compound (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189329 | Product containing xenon and/or xenon compound (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189329 | Product containing xenon and/or xenon compound (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189329 | Product containing xenon and/or xenon compound (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 218933 | Ordrine AT | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218937 | Oreton Methyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2189390 | Recombinant coagulation factor Xa | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189390 | Recombinant coagulation factor Xa | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189391 | Sisal dust | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189391 | Sisal dust | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189392 | Product containing precisely sodium chloride 9 milligram/1 milliliter conventional release solution for irrigation (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189392 | Product containing precisely sodium chloride 9 milligram/1 milliliter conventional release solution for irrigation (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189393 | Lichen acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189393 | Lichen acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189394 | Piperazine and/or piperazine derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189394 | Piperazine and/or piperazine derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189397 | Eflornithine hydrochloride monohydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189397 | Eflornithine hydrochloride monohydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 21894 | Cyanmethaemoglobin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 21894 | Cyanmethaemoglobin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 21894 | Cyanmethaemoglobin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218940 | Organidin NR | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218942 | Orinase Diagnostic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218943 | Orlaam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2189493 | Caffeine hydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189493 | Caffeine hydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189495 | Clemastine fumarate hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189495 | Clemastine fumarate hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218950 | Ortho Dienestrol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218951 | Ortho-Est | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218952 | Ortho-Gynol Contraceptive | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218956 | Orudis KT | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218959 | OsCal 500 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2189592 | Crotonobetainyl-CoA hydratase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189592 | Crotonobetainyl-CoA hydratase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189594 | Micronised collagen | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2189594 | Micronised collagen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189594 | Micronised collagen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189595 | Dapagliflozin propanediol monohydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189595 | Dapagliflozin propanediol monohydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189597 | Calcium electrolyte- and colecalciferol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189597 | Calcium electrolyte- and colecalciferol-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2189597 | Calcium electrolyte- and colecalciferol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218960 | Osmoglyn | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218963 | Otic Ear Care | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218964 | Otic Tridesilon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218965 | Otic care | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218966 | Oticaine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218967 | Otigesic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218968 | Otimar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218969 | Otobiotic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2189690 | Goserelin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189690 | Goserelin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218970 | Otocain | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218972 | Otocort Sterile Suspension | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218975 | Outgro Pain Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218977 | Oxistat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2189790 | Isophane insulin- and recombinant human soluble insulin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189790 | Isophane insulin- and recombinant human soluble insulin-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2189790 | Isophane insulin- and recombinant human soluble insulin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218985 | Oxy-Otic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218986 | Oxycontin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 218986 | Oxycontin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 218987 | Oxyfast | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218988 | Oxyfrin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2189890 | Nystatin-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189890 | Nystatin-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 218990 | Oxymeta-12 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218991 | Oysco 500 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218994 | Oyst Cal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 218995 | Oyst Cal 500 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2189990 | Olanzapine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189990 | Olanzapine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189991 | Amylase- and endopeptidase- and pancreatic lipase-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189991 | Amylase- and endopeptidase- and pancreatic lipase-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2189992 | Amylase- and endopeptidase- and triacylglycerol lipase-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2189992 | Amylase- and endopeptidase- and triacylglycerol lipase-containing product in oral dose form | Full form of descriptor (FN) | NO |